Aptevo Therapeutics
9 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of APVO436 in Elderly or Unfit Patients With Newly Diagnosed AML (NCT04973618) | Aptevo Therapeutics | 2025-01-01 |
| APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML (NCT06634394) | Aptevo Therapeutics | 2024-10-01 |
| ALG.APV-527 First-in-human Study (NCT05934539) | Aptevo Therapeutics | 2022-12-23 |
| Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis (NCT03768219) | Aptevo Therapeutics | 2019-03-18 |
Track Aptevo Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.